Navigation Links
Impaired recovery from inflammation linked to Alzheimer's

New research from Karolinska Institutet in Sweden shows that the final stage of the normal inflammatory process may be disrupted in patients with Alzheimer's disease. A study published in the journal Alzheimer's & Dementia shows that levels in the brain and cerebrospinal fluid of the molecules necessary for tissue recovery through the clearance of harmful inflammatory substances are lower than normal in patients with Alzheimer's disease. The study also showed association between the lower levels of these molecules with impaired memory function.

Alzheimer's disease is the most common form of dementia, eventually leading to neuronal death associated with an increasing degree of memory impairment. As with other neurodegenerative diseases, Alzheimer's is characterised by an inflammatory process in the brain. Prolonged inflammation with the release of inflammatory and toxic substances can cause further damage and neuronal death.

The inflammatory process normally ends in what is known as resolution. This is an active process regulated by certain molecules, so called specialized pro-resolving mediators, where the tissue is cleared from microorganisms, debris from dead cells via an uptake mechanism (phagocytosis), and where the release of growth factors stimulates tissue repair.

Together with colleagues in the United States, researchers at Karolinska Institutet have now shown that the levels of resolution-regulating molecules in the brain and in the cerebrospinal fluid are lower in Alzheimer's disease than normal. The researchers have also shown that the lower levels of these molecules correlate with a lower degree of cognitive function, that is, memory capacity. The results are based on analyses of cerebrospinal fluid from 15 patients with Alzheimer's disease, 20 patients with mild cognitive impairment and 21 control subjects. The researchers also analysed brain tissue from 10 Alzheimer's patients and 10 control subjects.

"Our hypothesis is that stimulation of resolution of inflammation in Alzheimer's disease may result in reduced neuronal death in the brain, and in turn have a beneficial effect in disease progression and cognition. This is an entirely new approach and provides the opportunity to develop new treatment principles for Alzheimer's disease," says Professor Marianne Schultzberg, who led the study at the Department of Neurobiology, Care Sciences and Society.

In ongoing studies, the researchers are now investigating how the pro-resolving molecules affect neuronal death in cell cultures, and whether treatment in animal experiments with these substances can prevent neurodegeneration and improve memory functions. The pro-resolving molecules identified so far are derivatives of omega-3 fatty acids, which constitute a popular food supple-ment that has been ascribed several health benefits, and have received attention for beneficial effects also on factors related to Alzheimer's disease, in line with the new results described above. In previous studies, the researchers behind these new findings have shown that omega-3 also stimulates cells to take up amyloid-beta, a protein that kills neurons and occurs in the brain in the form of plaques in Alzheimer's disease.


Contact: Press Office
Karolinska Institutet

Related biology news :

1. Impaired recovery of Atlantic cod -- forage fish or other factors?
2. Psychopaths have an impaired sense of smell
3. People with impaired glucose tolerance can show cognitive dysfunction
4. Research breakthrough: Impaired autophagy associated with age-related macular degeneration
5. Impaired cell division leads to neuronal disorder
6. University of Houston study shows BP oil spill hurt marshes, but recovery possible
7. Growth factor in stem cells may spur recovery from MS
8. Stanford scientists find molecule to starve lung cancer and improve ventilator recovery
9. New biofuel process dramatically improves energy recovery
10. After long-ago mass extinction, global warming hindered species recovery
11. Bone marrow stem cells do not improve short-term recovery after heart attack
Post Your Comments:
Related Image:
Impaired recovery from inflammation linked to Alzheimer's
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
(Date:11/9/2015)... Nov. 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... announced broader entry into the automotive market with a ... the pace of consumer electronics human interface innovation. Synaptics, ... ideal for the automotive industry and will be implemented ... Europe , Japan , ...
Breaking Biology News(10 mins):
(Date:11/24/2015)...  Clintrax Global, Inc., a worldwide provider of clinical research services ... that the company has set a new quarterly earnings record in ... growth posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... This fall, ... at competitive events in five states to develop and pitch their BIG ideas to ... from each state are competing for votes to win the title of SAP's Teen ...
(Date:11/24/2015)... 24, 2015 SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ...
(Date:11/24/2015)... -- Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting ... Israel time, at the law offices of ... th Floor, Tel Aviv, Israel . ... Izhak Tamir to the Board of Directors; , election of ... approval of an amendment to certain terms of options granted to our ...
Breaking Biology Technology: